Congenica closes B round
Congenica said April 27 that it closed a Series B round of funding. Additional investors include BGI Genomics, Healthlink Capital and Future Planet Capital. Congenica, of Cambridge, U.K., is a developer of clinical genomics software for inherited diseases.
27 April 2017•3 mins read
